A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer
Clinical trial NCT01215526 · COMPLETED
Trial details
- NCT number
- NCT01215526
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2015-07-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.